The distribution of two different vitamin D receptor polymorphisms (BsmI and start codon) in primary hyperparathyroidism

Journal of Internal Medicine

Volumn 247, Issue 1, 2000, Pages 124-130

  Sosa, Manuel ^a,c   Torres, A ^b   Martin N ^a   Salido, E ^b   Liminana J M ^a   Barrios, Y ^b   De Miguel, E ^a   Betancor, P ^a  

^a HOSPITAL UNIVERSITARIO INSULAR DE GRAN CANARIA   (Spain)

^b UNIVERSIDAD DE LA LAGUNA   (Spain)

^c UNIVERSITY OF LAS PALMAS DE GRAN CANARIA   (Spain)

Author keywords

Bone mineral density; FokI; Polymorphism; Postmenopausal women; Primary hyperparathyroidism; Vitamin D

Indexed keywords

VITAMIN D RECEPTOR;

ADULT; AGED; ARTICLE; BONE DENSITY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HUMAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; POSTMENOPAUSE; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; SPAIN;

AGED; ALLELES; BONE DENSITY; CASE-CONTROL STUDIES; DEOXYRIBONUCLEASES, TYPE II SITE-SPECIFIC; DNA PRIMERS; FEMALE; GENOTYPE; GERMANY; HUMANS; HYPERPARATHYROIDISM; MIDDLE AGED; ODDS RATIO; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POSTMENOPAUSE; RECEPTORS, CALCITRIOL; SWEDEN;

EID: 0033969995     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.2000.00593.x     Document Type: Article

References (33)

1. 1 Heppner C, Kester MB, Agarwal SK et al. Somatic mutation of the MENI gene in parathyroid tumours. Nat Genet 1997; 16: 375-78.
2. 2 Lundgren E. Rastad J. Akerström G, Ljundhall S. Health screening for primary hyperparathyroidism with serum calcium and parathyroid hormone values in menopausal women. Surgery 1997; 121: 287-94.
3. 3 Carling T. Kindmark A, Hellman P et al. Vitamin D receptor genotypes in primary hyperparathyroidism. Nature Med 1995; 1: 1309-11.
4. 4 Carling T. Kindmark A, Hellman P, Holmberg L, Akerstrom G, Rastad J. Vitamin D receptor alleles b, a, and T: risk factors for sporadic primary hyperparathyroidism (HPT) but not HPT of uremia or MEN 1. Biochem Biophys Res Commun 1997; 231; 329-32.
5. 5 Kaun M, Frilling A, Plaschke J. Saeger HD, Broelsch CE, Schackert HK. Vitamin D receptor genotypes in patients with primary and secondary hyperparathyroidism. Langenbecks Arch Chir Suppl Kongressbd 1997; 114: 773-75.
6. 6 Carling T, Ridefelt P, Hellman P, Rastad J, Akerström G. Vitamin D receptor polymorphisms correlate to parathyroid cell function in primary hyperparathyroidism. J Clin Endocrinol Metab 1997; 82: 1772-75.
7. 7 Morrison NA, Cheng J, Tokita A et al. Prediction of bone density from vitamin D receptor alleles. Nature 1994; 367: 284-87.
8. 8 Fernández E. Fibla J. Betriu A, Piulats JM, Almirall J, Monloliu J. Association between vitamin D receptor gene polymorphism and relative hypoparathyroidism in patients wity chronic renal failure. J Am Soc Nephrol 1997; 8: 1 546-52.
9. 9 Sosa Henríquez M, Torres Ramírez A, Domínguez Cabrera M, Salido E, Saavedra Santana P et al. Polimorfisino genético del receptor de la vitamina D y osteoporosis. Med Clin (Bare) 1998; 110: 646-50.
10. 10 Harris SS, Eccleshall TR, Gross C, Dawson-Hughes B, Feldman D. The vitamin D receptor start codon polymorphism (Fokl) and bone mineral density in premenopausal American black and white women. J Bone Miner Res 1997; 12: 1043-48.
11. 11 O'Neill TW, Felsenberg D. Varlow J, Cooper C. Kanis JA, Silman A and the European Vertebral Osteoporosis Study Group (EVOS). The prevalence of vertebral deformity in European men and women: The European Vertebral Osteoporosis Study. J Bone Miner Res 1996; 11: 1010-18.
12. 12 O'Neill TW, Cooper C, Cannata JB et al. on behalf of the European Vertebral Osteoporosis Study Group (EVOS). Reproducibility of a questionnaire on risk factors for osteoporosis in a multicentre prevalence survey: The European Vertebral Osteoporosis Study. Int J Epidemiol 1994; 23: 559-65.
13. 13 WHO Scientific Group on Research on the Menopause. Research on the menopause. WHO Technical Report 670. Geneva: WHO, 1981.
14. 14 Duboef F, Braillon P, Chapuy MC et al. Bone mineral density of the hip measured with dual-energy X-ray absorptiometry in normal elderly women and in patients with hip fracture. Osteoporosis Int 1991; 1: 242-49.
15. 15 Cann CE, Genant HK. Precise measurement of vertebral mineral content using computed tomography. J Comput Assist Tomogr 1980; 4: 493-500.
16. 16 Dïaz Curiel M, de Carrasco la Peña JL, Honorato Pérez J on behalf the Multicentre Research Project on Osteoporosis. Study of bone mineral density in lumbar spine and femoral neck in a Spanish population. Osteoporosis Int 1997; 7: 59-64.
17. 17 Nagasaka S, Ishikawa SI, Matoba H, Kubota K, Murakami T, Satto T. Vitamin D receptors and hyperparathyroidism. Nature Med 1996; 2: 834.
18. 18 Sato K, Kanbe M, Okamoto T et al. Vitamin D receptor gene polymorphism and bone mineral density in patients with primary hyperparathyroidism in Japan. J Bone Miner Res 1996; 11: S212.
19. 19 Salamone LM, Ferrell R, Black DM et al. The association between vitamin D receptor gene polymorphism and bone mineral density at the spine, hip and whole-body in premenopausal women. Osteoporosis Int 1996; 6: 63-68.
20. 20 Kung AWC, Yeung SSC, Lau KS. Vitamin receptor gene polymorphisms and peak bone mass in southern Chinese women. Bone 1998; 22: 389-93.
21. 21 Gross C, Eccleshall TR, Malloy PJ. Villa ML, Marcus R, Feldman D. The presence of a polymorphism at the translation initiation site of the vitamin D receptor gene is associated with low bone mineral density in postmenopausal Mexican-American women. J Bone Miner Res 1996; 11: 1850-55.
22. 22 Gross C, Krishan AV, Malloy PJ, Eccleshall TR, Zhao XY, Feldman D. The vitamin D receptor gene start codon polymorphism: a functional analysis of Fokl variants. J Bone Miner Res 1998; 13: 1691-99.
23. 23 Mitlak B, Smith A, Arnold A. Association of polymorphic allele of the vitamin D receptor gene with primary hyperparathyroidism in men and women. J Bone Miner Res 1996; 11: S212.
24. 24 Tanaka H, Tominaga Y, Seino Y. Vitamin D receptor genotypes may predict a risk of severe secondary hyperparathyroidism. J Bone Miner Res 1996; 11: S212.
25. 25 Carling T, Rastad J, Kindmark A et al. Estrogen receptor gene polymorphism in postmenopausal primary hyperparathyroidism. Surgery 1997; 122: 1101-106.
26. 26 Grey AB, Evans MC, Stapleton JP, Reid IR. Body weight and bone mineral density in postmenopausal women with primary hyperparathyroidism. Ann Intern Med 1994; 121: 745-49.
27. 27 Rico H. Revilla M, Arribas I, Villa LF, Alvarez de Buergo M. Total and regional bone mineral content in primary hyperparathyroidism. Miner Electrolyte Metabol 1994; 20: 112-16.
28. 28 Bergenfelz A, Lindergärd B, Ahren B. Biochemical variables associated with bone density in patients with primary hyperparathyroidism. Eur J Surg 1992; 158: 473-76.
29. 29 Christiansen P, Steiniche T, Brixen K et al. Primary hyperparathyroidism: biochemical markers and bone mineral density at multiple skeletal sites in Danish patients. Bone 1997; 21: 93-99.
30. 30 Consensus Development Conference Panel. Diagnosis and management of asymptomatic primary hyperparathyroidism: Consensus Development Conference Statement. Ann Intern Med 1991; 14: 593-97.
31. 31 Potts JT. Management of asymptomatic hyperparathyroidism. J Clin Endocrinol Metabol 1990; 70: 1489-93.
32. 32 Díaz Curiel M, Turbi Disla C, Peramo B, Rapado A. Tipos de afectación ósea en el hiperparatiroidismo primario. Rev Esp Enf Metab Oseas 1995; 4: 50-52.
33. 33 Van Doorn L, Lips P, Netelenbos JC, Hackeng HL. Bone histomorphometry and serum concentrations of intact parathyroid hormone (PTH 1-84) in patients with primary hyperparathyroidism. Bone Miner 1993; 23: 233-42.